The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pace Megan E since 2013.
The trader's CIK number is 1554979.
At the time of the last reporting, Pace Megan E was the SVP, Corp. Communications of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | VRTX | 0 | $0 | 72,710 | $7,875,594 | 69,220 | $3,574,475 |
| 2013 | VRTX | 0 | $0 | 44,557 | $3,583,066 | 36,000 | $1,364,950 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-11-17 | VRTX | Sale | 33 | 111.93 | 3,693 |
| 2014-09-30 | VRTX | Option Ex | 56,486 | 54.70 | 3,090,010 |
| 2014-09-30 | VRTX | Sale | 56,486 | 112.63 | 6,361,905 |
| 2014-06-24 | VRTX | Sale | 12,734 | 98.03 | 1,248,314 |
| 2014-06-24 | VRTX | Option Ex | 12,734 | 38.05 | 484,465 |
| 2014-05-15 | VRTX | Sale | 369 | 66.28 | 24,459 |
| 2014-05-02 | VRTX | Sale | 1,000 | 68.12 | 68,123 |
| 2014-01-21 | VRTX | Sale | 1,250 | 85.00 | 106,250 |
| 2014-01-06 | VRTX | Sale | 838 | 75.00 | 62,850 |
| 2013-12-12 | VRTX | Sale | 5,083 | 65.48 | 332,834 |
| 2013-11-15 | VRTX | Sale | 93 | 60.97 | 5,670 |
| 2013-07-11 | VRTX | Option Ex | 5,000 | 38.80 | 194,000 |
| 2013-07-12 | VRTX | Option Ex | 5,000 | 38.80 | 194,000 |
| 2013-07-11 | VRTX | Sale | 5,000 | 84.00 | 420,000 |
| 2013-07-12 | VRTX | Sale | 5,678 | 85.50 | 485,469 |
| 2013-07-08 | VRTX | Option Ex | 26,000 | 37.58 | 976,950 |
| 2013-07-08 | VRTX | Sale | 28,703 | 81.49 | 2,339,093 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pace Megan E (SVP, Corp. Communications of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.